ARCHIVES

Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down

This article is from The Cancer Letter archive.

Vol. 39 No. 22 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Terry To Leave NCI for Job As VP Of Revlon Health Care Group; NCI Tracking Source Of Breakthroughs

June 18, 1982

Varmus Pools $13.4 M. To Fund Projects; NCI Gives $2.6 Mil.

December 9, 1994

Linda Weiss, director of NCI Office of Cancer Centers, to Retire in March 2015

November 26, 2014

Protection Commission Asks Hew To Adopt Entire Report As Policy for Human Subject Research

April 27, 1979

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

March 23, 1994

Senate Approves Appropriations Bill; GRH Threatens It

October 23, 1987